SGLT2 inhibitors in clinical practice.

Rydén L, Norhammar A

The Lancet Diabetes & Endocrinology 12 (7) 434-435 [2024-07-00; online 2024-05-17]

PubMed 38768619

DOI 10.1016/S2213-8587(24)00133-5

Crossref 10.1016/S2213-8587(24)00133-5

pii: S2213-8587(24)00133-5


Publications 9.5.1